United States Cardiology Surgical and Interventional Devices Market to Witness Substantial Growth through 2025
Increasing prevalence of
cardiovascular diseases to fuel the growth of United States cardiology surgical
and interventional devices market
According to
TechSci Research report, “United States Cardiology Surgical and
Interventional Devices Market By Product Type
(Cardiovascular Surgical Devices, Interventional Devices), By Surgical Approach
(Open-Heart Surgery, Off-Pump Heart Surgery, Minimally Invasive Heart Surgery),
By Type of Cardiac Surgery (Coronary Artery Bypass Grafting (CABG),
Transmyocardial Laser Revascularization (TMR), Heart Valve Repair or Replacement,
Heart Transplant, Arrhythmia Treatment, Others), By End User (Hospitals &
Clinics, Ambulatory Surgical Centers, Others), By Region, Forecast &
Opportunities, 2025”, the market is anticipated to
grow at a significant CAGR during the forecast period owing to increasing
prevalence of cardiovascular diseases and advancements in healthcare technologies,
which has led to launch of effective, advanced and easy-to-use cardiology
surgical and interventional cardiology devices in the country. Moreover, rising
emphasis on effective, accurate, and early treatment of target diseases is
augmenting the growth of United States cardiology surgical and interventional
devices market. In addition to this, increasing awareness among patients and
high healthcare expenditure is expected to drive the market growth through
2025.
Furthermore, incessant technological advancements in surgical
and interventional cardiology devices is acting as a growth driver for this
market. The introduction of bioabsorble stents and new generation celect
platinum IVC (inferior vena cava) filter is further creating lucrative growth
opportunity for United States surgical and interventional cardiology devices
market. Also, growing geriatric population and increasing cases of coronary
artery diseases in the country are fueling the growth of surgical and
interventional cardiology devices market. However, stringent regulatory
guidelines and high cost of surgical and intervention cardiology procedures might
hamper the market growth.
Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on "United States Cardiology Surgical and Interventional Devices Market"
https://www.techsciresearch.com/report/united-states-cardiology-surgical-and-interventional-devices-market/5116.html
United States cardiology
surgical and interventional devices market is segmented based on product type,
surgical approach, type of cardiac surgery, end user and region. Based on product
type, the market is segmented into cardiovascular surgical devices and
interventional devices. The cardiovascular surgical devices segment is further
categorized into beating heart surgery system, cardiac ablation devices,
cardiopulmonary bypass equipment, perfusion disposables and others. Also, the interventional
devices segment can be split into artereotomy closure devices, cardiac
catheters, coronary guidewires, coronary stents and intravascular ultrasound
systems. Among them, the interventional devices are expected to register high
growth during the forecast period owing to increasing uses of stents during cardiac
surgeries.
Major players operating in the United
States cardiology surgical and interventional devices market include Biosense
Webster, Inc., Boston Scientific Corporation, C.R. Bard, Inc., Edwards
Lifesciences Corp., Medtronic. Inc., Cardinal Health Inc., Abbott Laboratories
Inc., Terumo Medical Corporation, Becton Dickinson and Company and Johnson
& Johnson. Key market players are focusing on launching novel products and
are undergoing mergers & collaboration to strengthen their market position.
Download
Sample Report @
https://www.techsciresearch.com/sample-report.aspx?cid=5116
Customers can
also request for 10% free customization on this report.
“The presence of
leading companies and availability of advanced healthcare infrastructure is making
United States a leading market for cardiology surgical and interventional
devices. Moreover, rapidly growing aging population has led to rise in
cardiology surgeries in the country. This is further expected to support the
demand for cardiology surgical and interventional devices such as stents and cardiopulmonary
bypass equipment,” said Mr. Karan Chechi, Research Director with TechSci
Research, a research based United States management consulting firm.
“United States Cardiology Surgical and
Interventional Devices Market By Product Type (Cardiovascular Surgical Devices,
Interventional Devices), By Surgical Approach (Open-Heart Surgery, Off-Pump
Heart Surgery, Minimally Invasive Heart Surgery), By Type of Cardiac Surgery
(Coronary Artery Bypass Grafting (CABG), Transmyocardial Laser
Revascularization (TMR), Heart Valve Repair or Replacement, Heart Transplant,
Arrhythmia Treatment, Others), By End User (Hospitals & Clinics, Ambulatory
Surgical Centers, Others), By Region, Forecast & Opportunities, 2025” has evaluated the future growth potential of United
States cardiology surgical and interventional devices market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges and opportunities in United States cardiology surgical and
interventional devices market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]